71 related articles for article (PubMed ID: 6150581)
1. The pharmacokinetics in man of SK&F 93319--a new antagonist of histamine H1 and H2 receptors.
Johnson P; Griffiths R; Lee RM; McDowall RD; Doyle E; Taylor DC; Burland WL
Xenobiotica; 1984 Jul; 14(7):589-93. PubMed ID: 6150581
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man.
Necciari J; Mery D; Garriot P; Escourrou J; Cautreels W
Int J Clin Pharmacol Res; 1985; 5(6):457-65. PubMed ID: 2869002
[TBL] [Abstract][Full Text] [Related]
3. Evidence for histamine H1 and H2 receptors in guinea-pig oxyntic cells.
Vinik AI; Heldsinger AA; Skoglund ML
J Pharmacol Exp Ther; 1983 Oct; 227(1):115-21. PubMed ID: 6137553
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of famotidine in man.
Kroemer H; Klotz U
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
[TBL] [Abstract][Full Text] [Related]
5. Oxmetidine (SK&F 92994): pharmacokinetic study in patients with in patients with liver cirrhosis.
Miglio F; Baraldini M; Serra S; Facchini A; Stefanini GF; Meliconi R; Gasbarrini G; Labo' G
Int J Clin Pharmacol Res; 1985; 5(6):399-404. PubMed ID: 2869000
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors.
Harvey CA; Owen DA
Br J Pharmacol; 1984 Oct; 83(2):427-32. PubMed ID: 6148984
[TBL] [Abstract][Full Text] [Related]
9. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
10. Effects of SK&F 93944 (Temelastine), a potent histamine H1-receptor antagonist in pharmacologic and antigen-induced bronchoconstriction.
Malo PE; Muccitelli R; Tucker SS; Wasserman MA
Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):461-8. PubMed ID: 2875234
[TBL] [Abstract][Full Text] [Related]
11. Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.
Powell JR; Donn KH
Am J Med; 1984 Nov; 77(5B):57-84. PubMed ID: 6150639
[TBL] [Abstract][Full Text] [Related]
12. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes.
Seligmann BE; Fletcher MP; Gallin JI
J Immunol; 1983 Apr; 130(4):1902-9. PubMed ID: 6131922
[TBL] [Abstract][Full Text] [Related]
13. [Biotransformation and pharmacokinetics of bamipine in rats. 2. Studies of the pharmacokinetics (1.)].
Neidlein VR; Kleiser M
Arzneimittelforschung; 1987 Feb; 37(2):174-7. PubMed ID: 2883979
[TBL] [Abstract][Full Text] [Related]
14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
15. One agonist and two receptors mediating the same effect: histamine receptors linked to adenylate cyclase in the brain.
Hough LB; Weinstein H; Green JP
Adv Biochem Psychopharmacol; 1980; 21():183-92. PubMed ID: 6103645
[No Abstract] [Full Text] [Related]
16. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
Prueksaritanont T; Gorham LM; Naue JA; Hamill TG; Askew BC; Vyas KP
Drug Metab Dispos; 1997 Mar; 25(3):355-61. PubMed ID: 9172954
[TBL] [Abstract][Full Text] [Related]
17. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
18. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
Seifert R; Höer A; Schwaner I; Buschauer A
Mol Pharmacol; 1992 Aug; 42(2):235-41. PubMed ID: 1381044
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of histamine receptor subtypes.
Arrang JM
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):275-81. PubMed ID: 7920174
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
Brown RD; Prendiville P; Cain C
Mol Pharmacol; 1986 Jun; 29(6):531-9. PubMed ID: 2872587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
